Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Creators
Ashu Singhal
No social account linked
Launched
47d ago
2026-09-29 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI sales agent that proves which ads actually make money

    Sep 29 · 47d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search29%
  • Referrals13%
  • Social7%
  • Other13%

Countries

  • India100%

Search

Domain authority —Domain registered 2026-08-18

KeywordMonthly volume
how to create a sequence of whatsapp status60

Traffic data: Vaneform

Pricing

Pay as you go
Free/month
5 credits per new lead
Pro
Unknown
Custom
Contact sales

Trial: 7-day free trial with free credits — no card · Enterprise custom tier · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-09-29

Key pages

Weekly snapshots
linkmodus.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does LinkModus cost?
Pay as you go: Free/month; Pro: Unknown; Custom: Contact sales. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does LinkModus get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is LinkModus and what platforms does it support?
LinkModus is catalogued under DM & Conversation Setting: Run AdsConvert LeadsGrow Revenue. Supported platforms: API.

Related products in this category

Sales / DM & Conversation Setting

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.